Thus, these results indicate that the increased rate of [Ca2+]i decline with β-adrenergic stimulation relied on ROS-independent phospholamban phosphorylation in both control and metabolic syndrome cardiomyocytes. The gene discussed is PLN; the disease is metabolic syndrome.